SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001193125-23-065309
Filing Date
2023-03-09
Accepted
2023-03-09 07:32:24
Documents
85
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K/A d472365d6ka.htm   iXBRL 6-K/A 115406
2 EX-99.1 d472365dex991.htm   iXBRL EX-99.1 875080
8 GRAPHIC g472365g04h85.jpg GRAPHIC 1885
9 GRAPHIC g472365g87u07.jpg GRAPHIC 2812
  Complete submission text file 0001193125-23-065309.txt   4980257

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA kzia-20221231.xsd EX-101.SCH 68045
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kzia-20221231_cal.xml EX-101.CAL 21771
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kzia-20221231_def.xml EX-101.DEF 202941
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE kzia-20221231_lab.xml EX-101.LAB 314430
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kzia-20221231_pre.xml EX-101.PRE 284577
79 EXTRACTED XBRL INSTANCE DOCUMENT d472365d6ka_htm.xml XML 883717
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 6-K/A | Act: 34 | File No.: 000-29962 | Film No.: 23718206
SIC: 2834 Pharmaceutical Preparations